Analysis reveals new MRI biomarkers predicting pathological response in breast cancer, highlighting model reliability.
Motivation: Accurate prediction of pathological completed response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer. Goal(s): Evaluate the value of potential MRI biomarkers for predicting pCR and establish a new nomogram to improve predictive performance. Approach: We conducted an analysis of 692 patients, utilizing univariable and multivariable logistic regression analyses, and training/validation cohorts for model development and validation. Results: Our newly developed model, combining the selected MRI parameters, hormone receptor (HR) and Ki67 index, exhibited strong predictive power, and also identified the rimed enhancement pre-NAC, and tumor size, wash-in slope, and ADC after NAC as significant imaging biomarkers of pCR. Impact: The impact of this study is significant, as it enhances breast cancer treatment by providing a reliable predictive model for neoadjuvant chemotherapy response, potentially improving patient outcomes and treatment strategies.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: